Insider Transactions in Q1 2021 at Akebia Therapeutics, Inc. (AKBA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2021
|
Steven Keith Burke SVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,400
+5.71%
|
-
|
|
Mar 16
2021
|
John P. Butler CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
39,520
+3.31%
|
-
|
|
Mar 16
2021
|
Michel Dahan SVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,648
+4.18%
|
-
|
|
Mar 16
2021
|
Nicole R. Hadas SVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,192
+3.59%
|
-
|
|
Mar 16
2021
|
Dell Faulkingham SVP, CCO |
BUY
Grant, award, or other acquisition
|
Direct |
9,152
+6.22%
|
-
|
|
Mar 16
2021
|
David A Spellman SVP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
7,592
+8.91%
|
-
|
|
Mar 01
2021
|
Steven Keith Burke SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,558
-4.47%
|
$22,674
$3.4 P/Share
|
|
Mar 01
2021
|
Michel Dahan SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
14,547
-2.73%
|
$43,641
$3.4 P/Share
|
|
Mar 01
2021
|
Nicole R. Hadas SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
14,285
-2.61%
|
$42,855
$3.4 P/Share
|
|
Mar 01
2021
|
Dell Faulkingham SVP, CCO |
SELL
Open market or private sale
|
Direct |
6,749
-4.98%
|
$20,247
$3.4 P/Share
|
|
Mar 01
2021
|
John P. Butler CEO and President |
SELL
Open market or private sale
|
Direct |
49,990
-2.17%
|
$149,970
$3.4 P/Share
|
|
Feb 26
2021
|
David A Spellman SVP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+50.0%
|
-
|
|
Feb 26
2021
|
Violetta Cotreau SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,000
+40.06%
|
-
|
|
Feb 26
2021
|
Steven Keith Burke SVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+29.29%
|
-
|
|
Feb 26
2021
|
Michel Dahan SVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,000
+18.69%
|
-
|
|
Feb 26
2021
|
Nicole R. Hadas SVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,000
+18.26%
|
-
|
|
Feb 26
2021
|
Dell Faulkingham SVP, CCO |
BUY
Grant, award, or other acquisition
|
Direct |
62,000
+31.38%
|
-
|
|
Feb 26
2021
|
John P. Butler CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
237,400
+16.91%
|
-
|